Safety and Tolerability Study of Oral EUR-1100 to Treat Eosinophilic Esophagitis

NCT01386112 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Eosinophilic Esophagitis

Interventions

DRUG: EUR-1100
DRUG: placebo

Sponsor

Forest Laboratories